Icon Wealth Advisors LLC Sells 209 Shares of Danaher Co. (NYSE:DHR)

Icon Wealth Advisors LLC decreased its position in shares of Danaher Co. (NYSE:DHR) by 6.1% in the 3rd quarter, HoldingsChannel reports. The fund owned 3,208 shares of the conglomerate’s stock after selling 209 shares during the period. Icon Wealth Advisors LLC’s holdings in Danaher were worth $892,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of the company. Fort Pitt Capital Group LLC grew its holdings in shares of Danaher by 3.2% during the third quarter. Fort Pitt Capital Group LLC now owns 238,092 shares of the conglomerate’s stock valued at $66,194,000 after buying an additional 7,421 shares during the last quarter. Good Life Advisors LLC bought a new stake in Danaher during the 3rd quarter worth approximately $217,000. Oak Thistle LLC purchased a new stake in shares of Danaher in the second quarter worth approximately $363,000. Harvest Portfolios Group Inc. lifted its holdings in shares of Danaher by 1.2% in the third quarter. Harvest Portfolios Group Inc. now owns 202,263 shares of the conglomerate’s stock valued at $56,233,000 after purchasing an additional 2,465 shares in the last quarter. Finally, Diversified Trust Co boosted its position in shares of Danaher by 75.4% during the second quarter. Diversified Trust Co now owns 4,360 shares of the conglomerate’s stock valued at $1,090,000 after buying an additional 1,874 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors.

Danaher Price Performance

Shares of NYSE DHR opened at $235.83 on Friday. The stock’s 50-day simple moving average is $258.15 and its two-hundred day simple moving average is $259.88. Danaher Co. has a twelve month low of $215.68 and a twelve month high of $281.70. The firm has a market capitalization of $170.33 billion, a P/E ratio of 45.01, a P/E/G ratio of 4.25 and a beta of 0.85. The company has a quick ratio of 1.01, a current ratio of 1.37 and a debt-to-equity ratio of 0.32.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, topping the consensus estimate of $1.57 by $0.14. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The company had revenue of $5.80 billion for the quarter, compared to analysts’ expectations of $5.59 billion. During the same period in the prior year, the business earned $2.02 earnings per share. Danaher’s revenue for the quarter was up 3.1% compared to the same quarter last year. As a group, equities analysts anticipate that Danaher Co. will post 7.5 EPS for the current fiscal year.

Danaher Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, October 25th. Investors of record on Friday, September 27th were given a $0.27 dividend. The ex-dividend date was Friday, September 27th. This represents a $1.08 annualized dividend and a yield of 0.46%. Danaher’s dividend payout ratio (DPR) is presently 20.61%.

Insider Activity at Danaher

In other Danaher news, SVP Georgeann Couchara sold 952 shares of Danaher stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $268.37, for a total transaction of $255,488.24. Following the transaction, the senior vice president now directly owns 4,212 shares of the company’s stock, valued at approximately $1,130,374.44. This trade represents a 18.44 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 11.10% of the stock is owned by insiders.

Analyst Ratings Changes

DHR has been the topic of several recent analyst reports. KeyCorp raised their price objective on Danaher from $290.00 to $310.00 and gave the company an “overweight” rating in a research note on Wednesday, October 23rd. Raymond James cut their price target on shares of Danaher from $310.00 to $300.00 and set an “outperform” rating on the stock in a report on Wednesday, October 23rd. Royal Bank of Canada decreased their price objective on shares of Danaher from $333.00 to $311.00 and set an “outperform” rating for the company in a research note on Wednesday, October 23rd. Stifel Nicolaus lifted their price target on Danaher from $250.00 to $265.00 and gave the stock a “hold” rating in a report on Wednesday, October 23rd. Finally, TD Cowen boosted their price target on shares of Danaher from $310.00 to $315.00 and gave the stock a “buy” rating in a report on Wednesday, October 23rd. Six research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. Based on data from MarketBeat, Danaher currently has a consensus rating of “Moderate Buy” and a consensus price target of $287.16.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.